DexCom, Inc. (DXCM)
68.94
+1.38
(+2.04%)
USD |
NASDAQ |
Dec 11, 16:00
69.02
+0.08
(+0.12%)
After-Hours: 20:00
DexCom Shareholders Equity (Quarterly): 2.726B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 50.95B |
| BioLife Solutions, Inc. | 353.74M |
| Boston Scientific Corp. | 23.39B |
| Insulet Corp. | 1.384B |
| Eli Lilly & Co. | 23.79B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.50B |
| Total Liabilities (Quarterly) | 4.774B |
| Debt to Equity Ratio | 0.9448 |
| Current Ratio | 1.565 |
| Net Debt Paydown Yield | 0.01% |